Tau-441 (2N4R) Wild-Type Oligomers (Baculovirus/Sf9)
Human Recombinant Tau-441 (2N4R) Wild-Type Oligomers (Baculovirus/Sf9)
Product Specifications
Background
Tau (tubulin-associated unit) is normally located in the axons of neurons where it stabilizes microtubules. Tauopathies such as Alzheimer’s Disease (AD) are characterized by neurofibrillary tangles containing hyper-phosphorylated tau fibrils (1) with consensus that tau oligomers are the most toxic species initiating neurodegeneration (2). Hyper-phosphorylated tau can be generated via expression in the Sf9/Baculovirus system, with up to 20 sites confirmed by mass spectrometry and western blots with phospho-specific antibodies (3). Our Sf9/Baculovirus-expressed Tau 2N4R oligomers are formed without the use of heparin or another anionic scaffold.
Product Name Alternative
MAPT, intracellular neurofibrillary tangles, NFTs, paired helical filaments, PHFs, 2N4R
UNSPSC
12352202
Swiss Prot
P10636-8
Host
Baculovirus/sf9
Origin Species
Human
Target
Wild-Type Tau
Conjugation
No Tag
Sequence
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL
Applications
WB, SDS-PAGE, Native-PAGE, In vivo assay, In vitro assay
Purification Method
Ion-exchange Purified
Concentration
2 mg/mL
Purity
>95%
Weight
0.02
Length
Full Length (1-441 aa)
Buffer
PBS pH 7.4
Molecular Weight
45.84 kDa
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For research use only.
Additionnal Information
Monomer source is catalog# SPR-496. For corresponding PFFs, see catalog# SPR-498.
References & Citations
1. Iqbal K., Liu F., and Gong C.X. 2016. Tau and neurodegenerative disease: The story so far. Nat. Rev. Neurol. DOI: 10.1038/nrneurol.2015.225
2. Puangmalai, N., Bhatt, N., Montalbano, M. et al. 2020. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies. Cell Death Dis. DOI: 10.1038/s41419-020-2503-3
3. Tepper et al. 2014. Oligomer Formation of Tau Protein Hyperphophorylated in Cells. The Journal of Biological Chemistry, DOI: 10.1074/jbc.M114.611368
Product MSDS
https://cdn.gentaur.com/products/400/212658762573/msds/spr-497c.pdf
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items